{"api":"v1","generated_at":"2026-09-16T00:05:12.565Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/clinicalintelpulse-theaslangroupllc-com-api-clinical-global-trials-6ce408","pinned_page":"https://tollindex.com/e/clinicalintelpulse-theaslangroupllc-com-api-clinical-global-trials-6ce408/at/2026-09-15T21-20Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-09-15T21:20:12.737Z","snapshot_stamp":"2026-09-15T21-20Z","endpoint":{"slug":"clinicalintelpulse-theaslangroupllc-com-api-clinical-global-trials-6ce408","canonical_url":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/global-trials","resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/global-trials","http_method":"GET","type":"http","x402_version":2,"registries":["cdp","binance"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gaps and unmet need by region. For CRO, global-pharma and advocacy agents.","service_name":"ClinicalIntelPulse","declared_category":null,"declared_tags":["global-trials","who-ictrp","china-trials","india-trials","global-health"],"route_template":null,"registry_updated":"2026-08-20T14:01:57.811Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"clinical global trials","category":"inference","first_observed_by_toll":"2026-09-10T19:08:24.178Z","last_observed_by_toll":"2026-09-15T21:20:12.737Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"binance","at":"2026-09-10T19:08:24.178Z","event":"listed"},{"registry":"cdp","at":"2026-09-10T19:08:24.178Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.15 USDC","amount_units":0.15,"decimals_known":true,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":1,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"GatewayWalletBatched","symbol":"USDC","decimals":6,"amount_display":"0.15 USDC","amount_units":0.15,"decimals_known":true,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":2,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","asset_name":null,"symbol":"USDC","decimals":6,"amount_display":"0.15 USDC","amount_units":0.15,"decimals_known":true,"pay_to":"985iFjbnGQ3dJcwXnfRCMSrH4Jnc3kW1N6msR64B5KX1","scheme":"exact"},{"registry":"cdp","ordinal":3,"network":"eip155:137","asset":"0x3c499c542cef5e3811e1192ce70d8cc03d5c3359","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.15 USDC","amount_units":0.15,"decimals_known":true,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":4,"network":"eip155:42161","asset":"0xaf88d065e77c8cc2239327c5edb3a432268e5831","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.15 USDC","amount_units":0.15,"decimals_known":true,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":5,"network":"eip155:480","asset":"0x79a02482a880bce3f13e09da970dc34db4cd24d1","asset_name":"USDC","symbol":null,"decimals":null,"amount_display":"150000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":6,"network":"eip155:143","asset":"0x754704bc059f8c67012fed69bc8a327a5aafb603","asset_name":"USDC","symbol":null,"decimals":null,"amount_display":"150000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":7,"network":"eip155:196","asset":"0x779ded0c9e1022225f8e0630b35a9b54be713736","asset_name":"USD₮0","symbol":null,"decimals":null,"amount_display":"150000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":8,"network":"eip155:999","asset":"0xb88339cb7199b77e23db6e890353e22632ba630f","asset_name":"USDC","symbol":null,"decimals":null,"amount_display":"150000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"cdp","ordinal":9,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","asset":"31566704","asset_name":null,"symbol":null,"decimals":null,"amount_display":"150000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"62A253YPATFNJCPRKID3FKD77MYJFNTVRYRP4B4JWG36EGLPY7UXFWGI7I","scheme":"exact"},{"registry":"cdp","ordinal":10,"network":"xrpl:0","asset":"XRP","asset_name":null,"symbol":null,"decimals":null,"amount_display":"150000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32","scheme":"exact"},{"registry":"cdp","ordinal":11,"network":"xrpl:0","asset":"524C555344000000000000000000000000000000","asset_name":null,"symbol":null,"decimals":null,"amount_display":"amount not declared","amount_units":null,"decimals_known":false,"pay_to":"rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32","scheme":"exact"},{"registry":"cdp","ordinal":12,"network":"eip155:56","asset":"0x8d0d000ee44948fc98c9b98a4fa4921476f08b0d","asset_name":"World Liberty Financial USD","symbol":null,"decimals":null,"amount_display":"150000000000000000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"exact"},{"registry":"binance","ordinal":0,"network":"eip155:56","asset":"0x8d0d000ee44948fc98c9b98a4fa4921476f08b0d","asset_name":null,"symbol":null,"decimals":null,"amount_display":"150000000000000000 smallest units, decimals unknown","amount_units":null,"decimals_known":false,"pay_to":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"eip3009"}],"counters":{"observed_at":"2026-09-15T21:20:12.737Z","calls_30d":2,"unique_payers_30d":1,"last_called_at":"2026-08-20T14:01:57.603Z"},"validation":{"latest":{"observed_at":"2026-09-15T05:26:18.930Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-09-15"},"uptime":[{"days":7,"observed":5,"passed":5,"ratio":1},{"days":30,"observed":5,"passed":5,"ratio":1},{"days":90,"observed":5,"passed":5,"ratio":1}],"history_90d":[{"observed_at":"2026-09-15T05:26:18.930Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-15","state_changed":false},{"observed_at":"2026-09-14T05:00:25.390Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-14","state_changed":false},{"observed_at":"2026-09-13T04:56:56.375Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-13","state_changed":false},{"observed_at":"2026-09-12T07:13:10.534Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-12","state_changed":false},{"observed_at":"2026-09-11T10:53:03.034Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-11","state_changed":true}]},"seller":{"wallet":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","page":"https://tollindex.com/seller/0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","endpoints":964,"hosts":78},"reports":0,"registry_record":{"cdp":[{"tags":["global-trials","who-ictrp","china-trials","india-trials","global-health"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"150000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":300},{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"GatewayWalletBatched","version":"1","verifyingContract":"0x77777777dcc4d5a8b6e418fd04d8997ef11000ee"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"150000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":604900},{"asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"Hc3sdEAsCGQcpgfivywog9uwtk8gUBUZgsxdME1EJy88"},"payTo":"985iFjbnGQ3dJcwXnfRCMSrH4Jnc3kW1N6msR64B5KX1","amount":"150000","scheme":"exact","network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","maxTimeoutSeconds":300},{"asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"150000","scheme":"exact","network":"eip155:137","maxTimeoutSeconds":300},{"asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"150000","scheme":"exact","network":"eip155:42161","maxTimeoutSeconds":300},{"asset":"0x79A02482A880bCe3F13E09da970dC34dB4cD24D1","extra":{"name":"USDC","version":"2"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"150000","scheme":"exact","network":"eip155:480","maxTimeoutSeconds":300},{"asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"150000","scheme":"exact","network":"eip155:143","maxTimeoutSeconds":300},{"asset":"0x779ded0c9e1022225f8e0630b35a9b54be713736","extra":{"name":"USD₮0","version":"1"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"150000","scheme":"exact","network":"eip155:196","maxTimeoutSeconds":300},{"asset":"0xb88339CB7199b77E23DB6E890353E22632Ba630f","extra":{"name":"USDC","version":"2"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"150000","scheme":"exact","network":"eip155:999","maxTimeoutSeconds":300},{"asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA"},"payTo":"62A253YPATFNJCPRKID3FKD77MYJFNTVRYRP4B4JWG36EGLPY7UXFWGI7I","amount":"150000","scheme":"exact","network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","maxTimeoutSeconds":300},{"asset":"XRP","extra":{"invoiceId":"ED0D5C057E914BD3BD3169924AD4D24F","sourceTag":804681468},"payTo":"rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32","amount":"150000","scheme":"exact","network":"xrpl:0","maxTimeoutSeconds":300},{"asset":"524C555344000000000000000000000000000000","extra":{"issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","invoiceId":"FC28848223CB4CF8B4E14B82FD4CD4B4","sourceTag":804681468},"payTo":"rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32","amount":"0.15","scheme":"exact","network":"xrpl:0","maxTimeoutSeconds":300},{"asset":"0x8d0D000Ee44948FC98c9B98A4FA4921476f08B0d","extra":{"name":"World Liberty Financial USD","version":"1","signerAddress":"0x34F7a661160780Ce1346e6D7B96D2bE244590899","assetTransferMethod":"eip3009"},"payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","amount":"150000000000000000","scheme":"exact","network":"eip155:56","maxTimeoutSeconds":300}],"quality":{"lastCalledAt":"2026-08-20T14:01:57.603Z","l30DaysTotalCalls":2,"l30DaysUniquePayers":1},"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/global-trials","extensions":{"bazaar":{"info":{"input":{"type":"http","method":"GET","queryParams":{"lang":"en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)","region":"global | africa | asia | europe | latin-america | middle-east | north-america (default: global)","condition":"Disease — e.g. \"Malaria\" | \"Tuberculosis\" | \"Dengue\" | \"Sickle Cell Disease\" | \"Chagas Disease\""}},"output":{"type":"json","example":{"query_summary":{"region":"global","condition":"Malaria"},"phase3_highlights":[{"drug":"R21/Matrix-M","notes":"WHO prequalification received 2023. First malaria vaccine with >75% efficacy in high-transmission settings.","sponsor":"Serum Institute / Oxford","countries":["Burkina Faso","Kenya","Mali","Tanzania"]}],"regulatory_landscape":{"ema":"Article 58 mechanism for non-EU disease burden assessments. R21 assessed via UK MHRA.","fda":"Limited footprint — malaria not a US priority market; few NDA filings","nmpa_china":"Artemisinin derivatives approved; combination therapies standardized under WHO guidelines","who_prequalification":"Primary pathway for SSA deployment. RTS,S and R21 both WHO-prequalified."},"unmet_needs_by_region":{"latin_america":"Vivax malaria (neglected vs. falciparum)","southeast_asia":"Artemisinin resistance (Pfkrelch mutations) — urgent — treatment of resistant falciparum","sub_saharan_africa":"Pediatric dosing, pregnancy, severe malaria, transmission blocking"},"opportunity_assessment":"R21 scale-up is the near-term priority. Resistance crisis in SE Asia creates urgent Phase 3 need for alternative regimens.","global_trial_distribution":{"most_active_countries":["Kenya (45 trials)","Uganda (38)","Burkina Faso (31)","Mali (28)","Tanzania (24)","United States (22)","Thailand (19)"],"clinicaltrials_gov_count":312,"geographic_concentration":"Sub-Saharan Africa dominates — 68% of all active malaria trials","estimated_non_us_registries":"200+ additional trials in WHO ICTRP member registries"},"global_registries_coverage":{"ctri_india":"18 trials — India significant manufacturer (Serum Institute)","chictr_china":"Limited malaria — primarily domestic infectious disease","anzctr_australia":"5 trials — malaria research centers in Melbourne (Burnet Institute)","clinical_trials_eu":"12 EU-registered trials"},"development_finance_context":"GAVI, Global Fund, UNITAID, PMI, USAID funding dominant. Wellcome Trust largest private funder."}}},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"queryParams":{"type":"object","properties":{"lang":{"type":"string"},"region":{"type":"string"},"condition":{"type":"string"}}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}},"builder-code":{"info":{"a":"bc_gxy6qn5p"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"a":{"type":"string","pattern":"^[a-z0-9_]{1,32}$","description":"App builder code"},"s":{"type":"array","items":{"type":"string","pattern":"^[a-z0-9_]{1,32}$"},"description":"Service builder codes"},"w":{"type":"string","pattern":"^[a-z0-9_]{1,32}$","description":"Wallet builder code"}},"additionalProperties":false}}},"description":"Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gaps and unmet need by region. For CRO, global-pharma and advocacy agents.","lastUpdated":"2026-08-20T14:01:57.811Z","serviceName":"ClinicalIntelPulse","x402Version":2}],"binance":[{"type":"http","accepts":[{"asset":"0x8d0D000Ee44948FC98c9B98A4FA4921476f08B0d","payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","scheme":"eip3009","network":"eip155:56","maxAmountRequired":"150000000000000000"}],"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/global-trials","description":"Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gaps and unmet need by region. For CRO, global-pharma and advocacy agents.","lastUpdated":1787408256206,"x402Version":2}]}}